Cannabidiol in the Treatment of Epilepsy: A Focused Review of Evidence and Gaps

Frontiers in Neurology
Guilherme Diogo SilvaLécio Figueira Pinto

Abstract

Approximately one third of epilepsy patients do not become seizure free with antiseizure medications. This treatment gap motivates research for new therapeutic options, such as cannabidiol (CBD). CBD differs from other cannabis derivatives because of its consistent efficacy and lack of a psychoactive effect. CBD can be recommended as adjunctive therapy in patients with Dravet and Lennox-Gastaut syndromes. The most common adverse effects (AEs) are drowsiness, reduced appetite, diarrhea, and vomiting. Transaminase elevation is the most common AE that leads to CBD discontinuation. Coadministration with valproate may increase the risk of hepatotoxicity. The combination of CBD and clobazam may increase both the effectiveness and the risk of AEs associated with these drugs. The most striking gaps in knowledge are the efficacy and optimal dose of CBD for adults with focal epilepsies, the long-term safety of CBD use, and strategies to improve access to CBD for people living with epilepsy.

References

Apr 1, 1978·Die Naturwissenschaften·R Mechoulam, E A Carlini
Dec 1, 1975·Canadian Journal of Physiology and Pharmacology·D D JohnsonW C Wilcox
Sep 24, 1982·European Journal of Pharmacology·P ConsroeR Mechoulam
May 1, 1981·The Journal of Heredity·B S FishR R Fox
Aug 1, 1981·Journal of Clinical Pharmacology·P ConsroeV Singh
Feb 15, 2002·BJOG : an International Journal of Obstetrics and Gynaecology·David M FergussonUNKNOWN ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood
Apr 24, 2012·Seizure : the Journal of the British Epilepsy Association·Nicholas A JonesClaire M Williams
Mar 7, 2014·The Cochrane Database of Systematic Reviews·David Gloss, Barbara Vickrey
May 24, 2014·Epilepsia·Edward Maa, Paige Figi
Oct 16, 2014·Lancet Neurology·Philippe RyvlinSylvain Rheims
Jun 24, 2015·JAMA : the Journal of the American Medical Association·Ryan VandreyMarcel O Bonn-Miller
Jun 27, 2015·Epilepsia·Alexandra L GeffreyElizabeth A Thiele
Sep 10, 2015·The New England Journal of Medicine·Daniel Friedman, Orrin Devinsky
Jan 3, 2016·Lancet Neurology·Orrin DevinskyMaria Roberta Cilio
May 26, 2017·The New England Journal of Medicine·Orrin DevinskyUNKNOWN Cannabidiol in Dravet Syndrome Study Group
Aug 7, 2017·Epilepsia·Tyler E GastonUNKNOWN UAB CBD Program
Aug 15, 2017·Annals of Internal Medicine·Shannon M NugentDevan Kansagara
Jan 19, 2018·Journal of Epilepsy Research·Emilio Perucca
Mar 8, 2018·Journal of Neurology, Neurosurgery, and Psychiatry·Emily StockingsLouisa Degenhardt
Mar 16, 2018·Neurology·Orrin DevinskyUNKNOWN GWPCARE1 Part A Study Group
May 17, 2018·The New England Journal of Medicine·Orrin DevinskyUNKNOWN GWPCARE3 Study Group
Mar 11, 2019·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Andrew J OcqueGene D Morse
Jun 22, 2019·British Journal of Clinical Pharmacology·S A MillarS E O'Sullivan
Jan 11, 2020·Frontiers in Neurology·Kerstin A KlotzJulia Jacobs
May 27, 2020·Epilepsia·Simona LattanziFrancesco Brigo

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.